Learn more

CHILDRENS HOSP & RES CT OAK

Overview
  • Total Patents
    149
  • GoodIP Patent Rank
    181,613
About

CHILDRENS HOSP & RES CT OAK has a total of 149 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TRIEU VUONG, UNIV CANBERRA and LINK GENOMICS INC.

Patent filings per year

Chart showing CHILDRENS HOSP & RES CT OAKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Granoff Dan M 32
#2 Moe Gregory R 26
#3 Oda Michael N 16
#4 Saba Julie D 13
#5 Ryan Robert O 12
#6 Welsch Jo Anne 11
#7 Hou Victor 9
#8 Granoff Dan 9
#9 Fyrst Henrik 9
#10 Morris Claudia R 9

Latest patents

Publication Filing date Title
WO2015073444A1 Methods and compositions for modulating serotonin levels
US2015154379A1 Method and system to facilitate care of a patient during transport
EP2750702A1 Engineered sequences to facilitate expression of antigens in neisseria and methods of use
WO2012174278A1 Ultra-small apob-containing particles and methods of use thereof
EP2702400A2 Compositions and methods to assess the capacity of hdl to support reverse cholesterol transport
EP2613636A1 Dietary supplement and methods of use thereof
EP2496597A2 T-cell stimulating protein b and methods of use
CN102711814A Chimeric factor h binding proteins (FHBP) and methods of use
CN102256619A Ex-vivo passive protection bacteremia assay
WO2010048343A2 System and method for accepting and processing a facsimile image
WO2009158678A1 Lipophilic nucleic acid delivery vehicle and methods of use therefor
WO2009126808A2 Transgenic animal model of cancer and methods of use
WO2009076598A1 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer
EP2185576A1 Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
US2009022736A1 Monoclonal antibodies that specifically bind to and neutralize bacillus anthracis toxin, compositions, and methods of use
US2008248032A1 Compositions and methods for protection against cardiac and/or central nervous system tissue injury by inhibiting sphingosine-1-phosphate lyase
US2008166721A1 Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease
KR20080091777A De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
US2008213787A1 Methods and compositions for KIR genotyping
WO2007027954A2 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof